1. P534: AZACITIDINE PLUS VENETOCLAX FOR THE TREATMENT OF RELAPSED AND FIRST-LINE AML PATIENTS. (23rd June 2022) Authors: Garciaz, S.; Hospital, M.-A.; Alary, A.-S.; Saillard, C.; Hicheri, Y.; Mohty, B.; Rey, J.; D'incan, E.; Charbonnier, A.; Ferdinand, V.; Maisano, V.; Lombardi, L.; Ittel, A.; Mozziconacci, M.-J.; Gelsi-Boyer, V.; Vey, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗